Zai Lab Net Income
| ZLAB Stock | USD 19.02 -0.04 -0.21% |
| = | -175.54 M |
Analyzing Zai Lab's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Zai Lab's current valuation and future prospects.
Latest Zai Lab's Net Income Growth Pattern
Below is the plot of the Net Income of Zai Lab over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Zai Lab financial statement analysis. It represents the amount of money remaining after all of Zai Lab operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Zai Lab's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zai Lab's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -175.54 M | 10 Years Trend |
|
Net Income |
| Timeline |
Zai Net Income Regression Statistics
| Arithmetic Mean | -169,806,085 | |
| Coefficient Of Variation | -111.80 | |
| Mean Deviation | 140,370,948 | |
| Median | -139,074,895 | |
| Standard Deviation | 189,840,162 | |
| Sample Variance | 36039.3T | |
| Range | 686.4M | |
| R-Value | -0.64 | |
| Mean Square Error | 22728T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | -24,035,772 | |
| Total Sum of Squares | 576628.6T |
Zai Net Income History
Other Related Fundumenentals
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Net Income component correlations
Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Zai Lab is extremely important. It helps to project a fair market value of Zai Stock properly, considering its historical fundamentals such as Net Income.
Click cells to compare fundamentals
| Competition |
Zai Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income | 31.18 Million |
Zai Lab's Net Income stands at -175.54 Million. This is 151.43% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 130.74% higher than that of the company.
Fundamental Drivers Relationships
Relative valuation benchmarks Zai Lab against sector multiples to estimate fair value. Cross-referencing Zai Lab's key ratios against peer benchmarks through ratio comparison sharpens the view on relative valuation and competitive positioning. More Info.Zai Lab is rated fourth in net income among leading competitors. It also is rated fourth in return on asset among leading competitors . Comparative financial data indicate that Net Loss is shifting by roughly 4.76%. Year-ago financials show Zai Lab with Net Loss of -175.54 Million. Valuation multiples such as P/E, P/B, and P/S compare Zai Lab to peer earnings performance.Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zai Lab's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to.Zai Lab is currently under evaluation in net income among leading competitors.
Current Valuation Drivers
We derive many important indicators used in calculating different scores of Zai Lab from analyzing Zai Lab's financial statements. These drivers represent accounts that assess Zai Lab's ability to generate profits relative to its revenue, operating costs, and shareholders'.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 603.4M | 301.7M | 256.1M | 2.7B | 1.9B | 2.0B | |
| Enterprise Value | -345.2M | -686.4M | -518.9M | 2.4B | 1.4B | 1.4B |
Institutional Holders
Institutional Holdings refers to the ownership stake in Zai Lab that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Zai Lab's outstanding shares and can exert considerable influence upon its management.| Shares | Wellington Management Company Llp | 2025-12-31 | 752.9 K | Mpm Oncology Impact Management Lp | 2025-09-30 | 745.1 K | Cam Group Holding A/s | 2025-12-31 | 510 K | Blackrock Inc | 2025-09-30 | 473.6 K | B Group, Inc | 2025-12-31 | 400 K | Legal & General Group Plc | 2025-12-31 | 387.8 K | Jane Street Group Llc | 2025-12-31 | 382.1 K | Walleye Trading Advisors, Llc | 2025-12-31 | 373.4 K | Ubs Group Ag | 2025-09-30 | 306.6 K | Rtw Investments, Llc | 2025-12-31 | 7 M | Clearbridge Advisors, Llc | 2025-09-30 | 3.5 M |
Important Fundamentals
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | -0.38 % | ||||
| Operating Margin | -0.54 % | ||||
| Current Valuation | 1.6 B | ||||
| Shares Outstanding | 110.64 M | ||||
| Shares Owned By Insiders | 1.77 % | ||||
| Shares Owned By Institutions | 30.04 % | ||||
| Number Of Shares Shorted | 3.8 M | ||||
| Price To Book | 2.95 X | ||||
| Price To Sales | 4.58 X | ||||
| Revenue | 460.16 M | ||||
| Gross Profit | 48.17 M | ||||
| EBITDA | -158.25 M | ||||
| Net Income | -175.54 M | ||||
| Cash And Equivalents | 1.26 B | ||||
| Cash Per Share | 13.10 X | ||||
| Total Debt | 224.26 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 7.91 X | ||||
| Book Value Per Share | 6.47 X | ||||
| Cash Flow From Operations | -150.79 M | ||||
| Short Ratio | 5.63 X | ||||
| Earnings Per Share | -1.60 X | ||||
| Price To Earnings To Growth | -0.17 X | ||||
| Target Price | 39.1 | ||||
| Number Of Employees | 1.78 K | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 2.11 B | ||||
| Total Asset | 1.17 B | ||||
| Retained Earnings | -2.63 B | ||||
| Working Capital | 603.12 M | ||||
| Net Asset | 1.17 B |
Financial Metrics, Fundamentals & Methodology
Zai Lab reports annual revenue of 460.16 M, a profit margin of -38.15%, ROE of -22.56%, debt-to-equity of 0.02. Zai Lab is commonly analyzed through earnings durability, financial structure, and capital deployment strategy. The company is currently operating at a loss. Overall market capitalization tier is mid-cap. For this reporting period, Zai Lab reflects revenue of 460.16 M, EPS loss of 1.6, negative operating margin of 54.4%.
Unless otherwise specified, data for Zai Lab is compiled from periodic company reporting and market reference feeds and standardized for comparability. Analyst projections are included when active coverage applies. Updates may occur throughout the day. Income statement, balance sheet, and cash-flow values follow GAAP or IFRS conventions as reported.